SCHEMBL17634239

SCHEMBL17634239

FC(F)(F)c1ccc(C2COc3c(Br)cccc3N2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
GAA P10253 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
PARP1 P09874 1/20 0.44
PARP2 Q9UGN5 1/20 0.44
AR P10275 1/20 0.44
HDAC11 Q96DB2 2/20 0.39
HDAC3 O15379 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
NCOR2 Q9Y618 1/20 0.37
HTR2C P28335 2/20 0.36
DRD2 P14416 1/20 0.34
DGAT1 O75907 1/20 0.33
TRPM8 Q7Z2W7 3/20 0.33
HTR1A P08908 1/20 0.32
BRD4 O60885 1/20 0.31
BRDT Q58F21 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2381413 0.83 GRIN2B (0.40) MEN1GAAKMT2AARTRPM8
SCHEMBL2378790 0.82 AR (0.46) MEN1GAAKMT2AALDH1A1MAPT
SCHEMBL17633638 0.80 KCNH2 (0.37) MEN1GAAKMT2AALDH1A1MAPT
SCHEMBL17634160 0.80 PARP1 (0.49) MEN1GAAKMT2AALDH1A1MAPT
SCHEMBL2378690 0.80 AR (0.38) MEN1GAAKMT2AAR
SCHEMBL2379042 0.76 AR (0.41) AR
SCHEMBL12247955 0.76 AR (0.40) AR
SCHEMBL2379360 0.76 AR (0.40) AR
SCHEMBL12300235 0.74 AR (0.38) ARHTR2CHTR1A
SCHEMBL2377614 0.74 AR (0.33) GAAALDH1A1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197900-B1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME (US) 2020-02-12 EP disclosed
US-9969752-B2 Inhibitors of HIF prolyl hydroxylase MERCK SHARP & DOHME CORP. (US) 2018-05-15 US disclosed
US-20170233412-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME CORP. (US) 2017-08-17 US disclosed
EP-3197900-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE Merck Sharp & Dohme Corp. (US) 2017-08-02 EP disclosed
WO-2016049099-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME CORP. (US) 2016-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170233412-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE HIF1AN, HIF1A, EGLN2 MEN1 4300/4885GAA 50/4885KMT2A 940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.